USP14/S100A11轴通过抑制细胞衰老来促进结直肠癌的进展
Yong Huang1, Xiaolei Tang2, Hao Xie1
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
Cell death & disease
|May 15, 2025
概括
在结肠直肠癌 (CRC) 中,S100A11被上调,通过抑制衰老来促进扩散和入侵. 针对USP14-S100A11轴为CRC患者提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在恶性瘤中注意到异常的S100A11表达.
- 它在结直肠癌 (CRC) 中的具体作用尚不清楚.
研究的目的:
- 研究S100A11在CRC中的表达和功能.
- 阐明S100A11在CRC进展中的潜在机制.
主要方法:
- 在CRC组织中分析S100A11表达.
- 在CRC细胞系中S100A11的体外淘汰.
- 在体内瘤生长和转移的测试.
- 研究S100A11与USP14的相互作用及其对衰老的影响.
主要成果:
- 在CRC中S100A11显著上调,与生存率差相关.
- S100A11 敲除抑制了CRC细胞的增殖,入侵和迁移.
- S100A11抑制细胞衰老,促进细胞的增殖和侵入.
- USP14二基化S100A11,这种相互作用对CRC细胞增殖至关重要.
结论:
- USP14-S100A11轴通过抑制衰老来促进CRC恶性瘤.
- 针对USP14-S100A11相互作用是CRC的潜在治疗策略.
相关概念视频
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


